human normal primary hepatocyte cell line Search Results


90
Celprogen Inc untransformed hepatocytes
Untransformed Hepatocytes, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/untransformed hepatocytes/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
untransformed hepatocytes - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PRIMACYT Cell Culture Technology GmbH primary human hepatocytes
Primary Human Hepatocytes, supplied by PRIMACYT Cell Culture Technology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human hepatocytes/product/PRIMACYT Cell Culture Technology GmbH
Average 90 stars, based on 1 article reviews
primary human hepatocytes - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Procell Inc wrl68 human embryonic liver cells
The effects of vincristine on <t>WRL68</t> cells and cell viability were assessed using the CCK-8 method. Cells were treated with different concentrations of vincristine (0.00, 0.01, 0.10, 1.00, 5.00, and 10.00 μg/mL) for 48 h at 37 °C. Data are presented as the means ± SEM determined from five independent experiments. **** P < 0.0001compared with the control group.
Wrl68 Human Embryonic Liver Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wrl68 human embryonic liver cells/product/Procell Inc
Average 90 stars, based on 1 article reviews
wrl68 human embryonic liver cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank hl-7702
The effects of vincristine on <t>WRL68</t> cells and cell viability were assessed using the CCK-8 method. Cells were treated with different concentrations of vincristine (0.00, 0.01, 0.10, 1.00, 5.00, and 10.00 μg/mL) for 48 h at 37 °C. Data are presented as the means ± SEM determined from five independent experiments. **** P < 0.0001compared with the control group.
Hl 7702, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hl-7702/product/JCRB Cell Bank
Average 90 stars, based on 1 article reviews
hl-7702 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Syngene immortalized human hepatocyte cell line miha
The effects of vincristine on <t>WRL68</t> cells and cell viability were assessed using the CCK-8 method. Cells were treated with different concentrations of vincristine (0.00, 0.01, 0.10, 1.00, 5.00, and 10.00 μg/mL) for 48 h at 37 °C. Data are presented as the means ± SEM determined from five independent experiments. **** P < 0.0001compared with the control group.
Immortalized Human Hepatocyte Cell Line Miha, supplied by Syngene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immortalized human hepatocyte cell line miha/product/Syngene
Average 90 stars, based on 1 article reviews
immortalized human hepatocyte cell line miha - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Servicebio Inc human normal hepatocyte cell line lo2
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Human Normal Hepatocyte Cell Line Lo2, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal hepatocyte cell line lo2/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
human normal hepatocyte cell line lo2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Makita human hepatocyte cell line huh7
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Human Hepatocyte Cell Line Huh7, supplied by Makita, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatocyte cell line huh7/product/Makita
Average 90 stars, based on 1 article reviews
human hepatocyte cell line huh7 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Stem Cell Research Center primary human hepatocytes (phhs)
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Primary Human Hepatocytes (Phhs), supplied by Stem Cell Research Center, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human hepatocytes (phhs)/product/Stem Cell Research Center
Average 90 stars, based on 1 article reviews
primary human hepatocytes (phhs) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
ZenBio human normal primary hepatocyte cell line
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Human Normal Primary Hepatocyte Cell Line, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal primary hepatocyte cell line/product/ZenBio
Average 90 stars, based on 1 article reviews
human normal primary hepatocyte cell line - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PRIMACYT Cell Culture Technology GmbH primary human hepatocyte batches bhuf16087
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Primary Human Hepatocyte Batches Bhuf16087, supplied by PRIMACYT Cell Culture Technology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human hepatocyte batches bhuf16087/product/PRIMACYT Cell Culture Technology GmbH
Average 90 stars, based on 1 article reviews
primary human hepatocyte batches bhuf16087 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc normal human hepatocytes cell line wrl68
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Normal Human Hepatocytes Cell Line Wrl68, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human hepatocytes cell line wrl68/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
normal human hepatocytes cell line wrl68 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank human primary hepatocytes
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Human Primary Hepatocytes, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human primary hepatocytes/product/JCRB Cell Bank
Average 90 stars, based on 1 article reviews
human primary hepatocytes - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


The effects of vincristine on WRL68 cells and cell viability were assessed using the CCK-8 method. Cells were treated with different concentrations of vincristine (0.00, 0.01, 0.10, 1.00, 5.00, and 10.00 μg/mL) for 48 h at 37 °C. Data are presented as the means ± SEM determined from five independent experiments. **** P < 0.0001compared with the control group.

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: The effects of vincristine on WRL68 cells and cell viability were assessed using the CCK-8 method. Cells were treated with different concentrations of vincristine (0.00, 0.01, 0.10, 1.00, 5.00, and 10.00 μg/mL) for 48 h at 37 °C. Data are presented as the means ± SEM determined from five independent experiments. **** P < 0.0001compared with the control group.

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: CCK-8 Assay, Control

The averaged absorption spectra of WRL68 cells that were untreated (control group, black) and treated with 0.120 μg/mL vincristine (treated group, red).

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: The averaged absorption spectra of WRL68 cells that were untreated (control group, black) and treated with 0.120 μg/mL vincristine (treated group, red).

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: Control

The vector-normalized averaged second-derivative spectra of the WRL68 cells that were untreated (control, black) and treated with vincristine (red).

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: The vector-normalized averaged second-derivative spectra of the WRL68 cells that were untreated (control, black) and treated with vincristine (red).

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: Plasmid Preparation, Control

(a) PCA score plot of the vector-normalized second-derivative spectra from the WRL68 cells in the lipid region (3000–2800 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.925, R 2 Y = 0.704, Q 2 = 0.651). The x - and y -axes indicate the first component t1 and the first orthogonal component to1. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean ν as (CH 2 )/ν as (CH 3 ) and ν s (CH 2 )/ν s (CH 3 ) peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated cells, **** P < 0.0001compared with the control group.

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: (a) PCA score plot of the vector-normalized second-derivative spectra from the WRL68 cells in the lipid region (3000–2800 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.925, R 2 Y = 0.704, Q 2 = 0.651). The x - and y -axes indicate the first component t1 and the first orthogonal component to1. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean ν as (CH 2 )/ν as (CH 3 ) and ν s (CH 2 )/ν s (CH 3 ) peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated cells, **** P < 0.0001compared with the control group.

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: Plasmid Preparation, Control

(a) PCA score plot of the vector-normalized second-derivative spectra from WRL68 cells in the protein region (1800–1480 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.961, R 2 Y = 0.617, Q 2 = 0. 511). The x - and y -axes indicate the first component t1 and the first orthogonal component to1, respectively. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean protein amide I/amide II (1670–1646/1563–1531) and α-helix/β-sheet (1670–1646/1644–1621) absorption band peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated cells. **** P < 0.0001 and *** P < 0.001 compared with the control group.

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: (a) PCA score plot of the vector-normalized second-derivative spectra from WRL68 cells in the protein region (1800–1480 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.961, R 2 Y = 0.617, Q 2 = 0. 511). The x - and y -axes indicate the first component t1 and the first orthogonal component to1, respectively. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean protein amide I/amide II (1670–1646/1563–1531) and α-helix/β-sheet (1670–1646/1644–1621) absorption band peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated cells. **** P < 0.0001 and *** P < 0.001 compared with the control group.

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: Plasmid Preparation, Control

(a) PCA score plot of the vector-normalized second-derivative spectra from the WRL68 cells in the fingerprint region (1480–900 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.597, R 2 Y = 0.873, Q 2 = 0. 754). The x - and y -axes indicate the first component t1 and the first orthogonal component to1, respectively. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean nucleic acid ν as (PO 2 – )/lipid ester ν(C=O) (1269–1201/1754–1723), nucleic acid ν as (PO 2 – )/protein amide II (1269–1201/1563–1531), nucleic acid ν s (PO 2 – )/lipid ester ν(C=O) (1105–1070/1754–1723), nucleic acid ν s (PO 2 – )/protein amide II (1105–1070/1563–1531), and nucleic acid ν s (dianionic phosphate monoester)/lipid ester ν(C=O) (984–948/1754–1723) peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated groups. **** P < 0.0001 compared with the control group.

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: (a) PCA score plot of the vector-normalized second-derivative spectra from the WRL68 cells in the fingerprint region (1480–900 cm –1 ). (b) Loading plots of PC1 and PC2 from the PCA model. (c) OPLS-DA score plot ( R 2 X = 0.597, R 2 Y = 0.873, Q 2 = 0. 754). The x - and y -axes indicate the first component t1 and the first orthogonal component to1, respectively. The y -axis displays the within-class variability (intraclass discrimination), and the x -axis displays the separation between the control and treated groups (interclass discrimination). The gray circle refers to the 95% confidence ellipse. (d) Mean nucleic acid ν as (PO 2 – )/lipid ester ν(C=O) (1269–1201/1754–1723), nucleic acid ν as (PO 2 – )/protein amide II (1269–1201/1563–1531), nucleic acid ν s (PO 2 – )/lipid ester ν(C=O) (1105–1070/1754–1723), nucleic acid ν s (PO 2 – )/protein amide II (1105–1070/1563–1531), and nucleic acid ν s (dianionic phosphate monoester)/lipid ester ν(C=O) (984–948/1754–1723) peak area ratio values measured from the second-derivative spectra of the control and vincristine-treated groups. **** P < 0.0001 compared with the control group.

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques: Plasmid Preparation, Control

Assignments of the Most Relevant IR Absorption Bands of  WRL68  Cells, Together with the Related Vibrational mode <xref ref-type= 28 − 30 " width="100%" height="100%">

Journal: ACS Omega

Article Title: Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level

doi: 10.1021/acsomega.2c06622

Figure Lengend Snippet: Assignments of the Most Relevant IR Absorption Bands of WRL68 Cells, Together with the Related Vibrational mode 28 30

Article Snippet: WRL68 human embryonic liver cells (obtained from Procell Life Science & Technology Co., Ltd.) were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, obtained from KeyGEN BioTECH) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO 2 saturation in a humidified atmosphere.

Techniques:

Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in LO2 and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.

Journal: Translational Cancer Research

Article Title: Analysis of the role of POC1A in the development and progression of hepatocellular carcinoma

doi: 10.21037/tcr-23-2398

Figure Lengend Snippet: Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in LO2 and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.

Article Snippet: The human normal hepatocyte cell line LO2 (Servicebio Technology Co., Ltd., Wuhan, China) was cultured in Roswell Park Memorial Institute 1640 medium, and the hepatoma cell line HepG2 (Procell Life Science & Technology Co., Ltd., Wuhan, China) was cultured in Dulbecco’s Modified Eagle Medium (Hyclone, Thermo Fisher Scientific Inc., Waltham, MA), supplemented with 10% fetal bovine serum and antibiotics (10,000 U/mL penicillin and 10 mg/mL streptomycin) (Procell Life Science & Technology Co., Ltd.).

Techniques: Expressing, Comparison, Immunohistochemical staining, Real-time Polymerase Chain Reaction